Lifesci Capital Lowers Inhibrx (NASDAQ:INBX) to Market Perform
Lifesci Capital downgraded shares of Inhibrx (NASDAQ:INBX – Free Report) from an outperform rating to a market perform rating in a report issued on Tuesday morning, PriceTargets.com reports. Separately, JMP Securities reaffirmed a market perform rating on shares of Inhibrx in a research report on Tuesday. View Our Latest Research Report on INBX Inhibrx Stock […]
More Stories
The Diplomat Season 5 Renewed! Release Date, Cast, Plot, and More
The Diplomat, an American political thriller series, has captivated viewers since 2023. Four seasons have already aired, and fans are...
175 House Democrats Call for Halt to Ilhan Omar Investigation
By Guy Birchall Scores of House Democrats have called for an end to the federal investigation into Rep. Ilhan Omar...
Gas Prices, Housing, Interest Rates: Inside the US Cost-of-Living Picture Ahead of the Midterms
Andrew Moran, Kevin Stocklin and Emel Akan As voters weigh the economic records of both parties ahead of the midterms,...
2 Men Charged in UK Over Military Base Incident Allegedly Linked to Iran
By Rachel Roberts Two men were charged under the UK’s National Security Act on Oct. 27 over last month’s incident...
Trump Announces EPA Will Roll Back Biden-Era Methane Regulations on Oil and Gas Producers
By Tom Gantert President Donald Trump announced Tuesday night in Lubbock, Texas, that his administration would roll back Biden-era methane...
Treasury Department Ends Ownership Reporting for US Small Businesses
By Owen Evans The Treasury Department on Aug. 11 finalized a rule permanently exempting U.S. companies and individuals from reporting...